CellPlan is an affordable insurance product designed to enable families to receive stem cell transplantation using cord blood they have banked. CellPlan provides worldwide access to stem cell specialists and hospitals, including cover for up £1million in medical, travel and accommodation expenses.
Families who have stored their child’s cord blood in a private bank, and who have CellPlan healthcare cover, can take comfort in the knowledge that if the time comes to use the cord blood, they have the medical and financial support on hand to provide crucial assistance. For those who cannot afford to store the blood of additional siblings, or for those who did not store the blood of their earlier children, extending insurance coverage would ensure that all children have cover should a child’s stem cells become useful to another sibling.
Simply complete your ‘quick quote’ and we’ll guide you through the process.
You can request your quote by email and download the policy wording, or you can request CellPlan's digital brochure. If you have any doubts a member of our team will be able to advise you.
This is the blood remaining in the umbilical cord and placenta following the birth of a baby and clamping of the umbilical cord. Cord blood can be easily collected after birth, processed and stored for future use.
Cord blood contains stem cells similar to those found in bone marrow. This is why cord blood can be used for transplantation as an alternative to bone marrow.
The stem cells in cord blood are able to produce all of the cells in our normal blood circulation. Cord blood stem cells are haematopoietic stem cells and can be used to treat a range of blood disorders.
HLA are surface markers on our cells which help our body to identify cells that belong to us and cells that do not. A match of these markers in the donor and recipient is required when a transplant takes place, if not our body will attack foreign cells which are not matched to our own.
None. The cord blood collected and stored from a baby is a perfect HLA match to that baby and is readily available, if it has been collected, processed and stored for a transplant.
We inherit our HLA markers from our parents. It has been shown that cord blood can be successfully transplanted to family members with up to a 50% mismatch in HLA markers. This reflects the immunologically ‘naïve’ nature of cord blood stem cells, hich is a great advantage when carrying out stem cell transplantation. Most cord blood transplants to date have been carried out to siblings and parents of the donor baby.
During a lifetime of 70 years the likelihood of a person requiring a transplant of their own or another's stem cells has been estimated at 1 in 217*
* Reference: JJ Nietfield, MC Pasquini, BR Logan, F.Verter, MM Horowitz Lifetime Probabilities of Hematopoetic Stem Cell Transplantation in the U.S.
Published in: Biology of Blood and Marrow Transplantation 2008;14:316-322
Cord blood stem cells can be used to treat a range of over 80 blood disorders such as leukaemia, sickle cell disease and Fanconi’s anaemia. Research and clinical trials are also underway to utilise cord blood stem cells in the treatment of many other diseases for example cerebral palsy.
Yes, in most cases, the stem cells collected can be used to treat siblings and parents.
Donated units have to be matched to the recipient; therefore even an international search may result in no match.
Cord blood stem cells are known to have remained viable - and, in fact, in the same condition as the day they were frozen - after more than 20 years of storage.
You can click on our Find a Cord Blood Bank section, and locate a CellPlan Excel member cord blood bank in your area.
We are sorry to hear that you are considering cancelling your cover. Please speak to our team before you go ahead. They will listen to your needs and you can decide the best way forward for your family.
CellPlan is underwritten by one of the largest reinsurers in the world.
Cord blood stem cells have been used for 20 years in the treatment of more than 80 different blood diseases. They have been used in more than 40,000 transplants so far.